Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Hereditary angioedema: beyond swelling

Paul A. Kyrle, Sabine Eichinger

Blood (2024) 144 (4): 354–355.

https://doi.org/10.1182/blood.2024024958

Published: 2024

Journal Articles

Identification of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence Estimated By the Vienna Prediction Model: A Prospective Cohort Management Study

Sabine Eichinger, Lisbeth Eischer, Hana Šinkovec, Paul Gressenberger, Thomas Gary, Marianne Brodmann, Georg Heinze, Paul A. Kyrle

Blood (2021) 138 (Supplement 1): 775.

https://doi.org/10.1182/blood-2021-150934

Published: 2021

Journal Articles

How I manage cyclic thrombocytopenia

Paul A. Kyrle, Sabine Eichinger

Blood (2021) 137 (2): 178–184.

https://doi.org/10.1182/blood.2020008218

Published: 2021

Journal Articles

Recurrent Venous Thromboembolism during Anticoagulation: An Investigator-Initiated Post-Hoc Analysis of the Hokusai-VTE Trial

Sabine Eichinger, MD, Min Lin, PhD, Paul A. Kyrle, MD, Michael A. Grosso, MD

Blood (2018) 132 (Supplement 1): 2539.

https://doi.org/10.1182/blood-2018-99-118093

Published: 2018

Journal Articles

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

Paul A Kyrle, MD, Michael Kammer, Lisbeth Eischer, Georg Heinze, Sabine Eichinger, MD

Blood (2016) 128 (22): 273.

https://doi.org/10.1182/blood.V128.22.273.273

Published: 2016

Journal Articles

How I treat recurrent deep-vein thrombosis

Paul A. Kyrle

Blood (2016) 127 (6): 696–702.

https://doi.org/10.1182/blood-2015-09-671297

Published: 2016

Journal Articles

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

Sabine Eichinger, MD, Paul A Kyrle, MD, Michael Kammer, MSc, Lisbeth Eischer, MD, Christoph Binder, MD

Blood (2014) 124 (21): 2861.

https://doi.org/10.1182/blood.V124.21.2861.2861

Published: 2014

Journal Articles

D-Dimer Levels Over Time and The Risk Of Recurrent Venous Thromboembolism: An Update Of The Vienna Prediction Model

Sabine Eichinger, MD, Georg Heinze, Paul A Kyrle, MD

Blood (2013) 122 (21): 462.

https://doi.org/10.1182/blood.V122.21.462.462

Published: 2013

Journal Articles

The Risk Of Recurrence In Women With Venous Thromboembolism While Using Estrogens: A Prospective Observational Cohort Study

Paul A Kyrle, MD, Lisbeth Eischer, MD, Sabine Eichinger, MD

Blood (2013) 122 (21): 1123.

https://doi.org/10.1182/blood.V122.21.1123.1123

Published: 2013

Journal Articles

Is Virchow's triad complete?

Paul A. Kyrle, Sabine Eichinger

Blood (2009) 114 (6): 1138–1139.

https://doi.org/10.1182/blood-2009-05-223511

Published: 2009

Journal Articles

Quantification of ADAMTS-13 Activity and Antigen from the Same Sample by a Newly Developed Combi-Actibind Assay (TECHNOZYM® ADAMTS-13).

Sabine Geiter, MS, Sebastién Colle, Ms, Paul A. Kyrle, MD, Fritz Scheiflinger, PhD, Bernd R. Binder, MD, Helga Vetr, PhD

Blood (2006) 108 (11): 1065.

https://doi.org/10.1182/blood.V108.11.1065.1065

Published: 2006

Journal Articles

Risk of Recurrent Venous Thromboembolism Reduced by High Density Lipoproteins.

Sabine Eichinger, MD, Natalie M. Pecheniuk, Ph.D., Gregor Hron, M.D., Hiroshi Deguchi, M.D., Ph.D., Paul A. Kyrle, M.D., John H. Griffin, Ph.D.

Blood (2006) 108 (11): 271.

https://doi.org/10.1182/blood.V108.11.271.271

Published: 2006

Journal Articles

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago

Ariella Zivelin, Ronit Mor-Cohen, Victoria Kovalsky, Nurit Kornbrot, Jacqueline Conard, Flora Peyvandi, Paul A. Kyrle, Rogier Bertina, Ferial Peyvandi, Joseph Emmerich, Uri Seligsohn

Blood (2006) 107 (12): 4666–4668.

https://doi.org/10.1182/blood-2005-12-5158

Published: 2006

Journal Articles

Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism.

Sabine Eichinger, MD, Gregor Hron, MD, Ansgar Weltermann, MD, Marietta Kollars, Paul A. Kyrle, MD

Blood (2005) 106 (11): 1622.

https://doi.org/10.1182/blood.V106.11.1622.1622

Published: 2005

Journal Articles

Tissue Factor-Exposing Microparticles at the Site of Hemostasis Activation.

Verena Gartner, MD, Barbara Lubscyk, Marietta Kollars, Paul A. Kyrle, MD, Ansgar Weltermann, MD

Blood (2005) 106 (11): 3944.

https://doi.org/10.1182/blood.V106.11.3944.3944

Published: 2005

Journal Articles

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism

Sabine Eichinger, Verena Schönauer, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Barbara Schneider, Peter Quehenberger, Paul A. Kyrle

Blood (2004) 103 (10): 3773–3776.

https://doi.org/10.1182/blood-2003-10-3422

Published: 2004

Journal Articles

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism

Ingrid Pabinger, Helga Grafenhofer, Paul A. Kyrle, Peter Quehenberger, Christine Mannhalter, Klaus Lechner, Alexandra Kaider

Blood (2002) 100 (3): 1060–1062.

https://doi.org/10.1182/blood-2002-01-0149

Published: 2002

NARROW

Hereditary angioedema: beyond swelling

Identification of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence Estimated By the Vienna Prediction Model: A Prospective Cohort Management Study

How I manage cyclic thrombocytopenia

Recurrent Venous Thromboembolism during Anticoagulation: An Investigator-Initiated Post-Hoc Analysis of the Hokusai-VTE Trial

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

How I treat recurrent deep-vein thrombosis

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

D-Dimer Levels Over Time and The Risk Of Recurrent Venous Thromboembolism: An Update Of The Vienna Prediction Model

The Risk Of Recurrence In Women With Venous Thromboembolism While Using Estrogens: A Prospective Observational Cohort Study

Is Virchow's triad complete?

Quantification of ADAMTS-13 Activity and Antigen from the Same Sample by a Newly Developed Combi-Actibind Assay (TECHNOZYM® ADAMTS-13).

Risk of Recurrent Venous Thromboembolism Reduced by High Density Lipoproteins.

Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago

Endogenous Thrombin Potential (ETP) for Assessing the Risk of Recurrent Venous Thromboembolism.

Tissue Factor-Exposing Microparticles at the Site of Hemostasis Activation.

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only